Funding agencies: This study was supported by the Parkinson Disease Research, Education, and Clinical Center of the Portland VA Medical Center, the RJG Foundation, and the Oregon Clinical and Translational Research Institute (grant UL1 RR024140).
Version of Record online: 16 APR 2012
Copyright © 2012 Movement Disorder Society
Volume 27, Issue 6, pages 750–753, May 2012
How to Cite
Brod, L. S., Aldred, J. L. and Nutt, J. G. (2012), Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease. Mov. Disord., 27: 750–753. doi: 10.1002/mds.24998
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 30 MAY 2012
- Version of Record online: 16 APR 2012
- Manuscript Revised: 15 FEB 2012
- Manuscript Accepted: 14 JAN 2012
- Manuscript Received: 7 DEC 2011
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.